EMA and FDA encourage use of innovative approaches in the development of medicines for Gaucher disease

View source ↗

Summary

EMA and FDA encourage the use of innovative development approaches to speed up and improve medicines for Gaucher disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease